WKN DE: A40EP8 / ISIN: US75383L1026

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Rapport Therapeutics Times and Sales (NAS)

Zeit	Kurs	Umsatz (Stk)
20:54:14	41,620	48
20:54:14	41,630	7
20:54:14	41,660	12
20:54:14	41,660	2
20:54:14	41,660	5
20:54:14	41,660	7
20:54:14	41,660	1
20:54:14	41,650	19
20:54:14	41,650	27
20:54:14	41,650	27
20:54:14	41,650	27
20:54:14	41,615	100
20:52:19	41,570	27
20:49:04	41,570	21
20:49:04	41,570	25
20:49:04	41,570	25
20:49:04	41,575	25
20:49:04	41,575	3
20:48:47	41,660	95
20:48:47	41,650	5
20:45:14	41,640	86
20:45:14	41,630	5
20:45:06	41,575	3
20:43:33	41,630	100
20:43:26	41,580	9
20:43:19	41,580	2
20:42:50	41,580	3
20:39:48	41,570	10
20:39:48	41,570	10
20:39:48	41,570	10
20:39:23	41,630	3
20:38:47	41,570	1
20:38:23	41,570	5
20:37:30	41,640	100
20:32:57	41,710	26

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Rapport Therapeutics Inc Registered Shs

Weitere Meldungen

14:49		Jim Cramer: This Tech Stock Is A ‘Speculative Buy’ Here
14:49		Buffett drops Gates Foundation from $6bn Berkshire donation
14:49		Tesla and Meta Are Worth Almost the Same. Which Stock Is the Better Buy?
14:48		Goldman's profit jumps on trading surge, corporate deal spree
14:40		How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q2 Earnings
14:39		Cerebras CEO Andrew Feldman Says Elon Musk Found a ‘Pretty Good Idea’ in Leasing SpaceXAI’s Unused Grok Capacity to Anthropic
14:36		New York Just Hit Brakes on AI: Kathy Hochul To Reportedly Freeze New 50 MW Data Centers Amid Grid Strain
14:34		Consumer prices fall for first time since early days of COVID pandemic, but war against high inflation isn’t won
14:31		This Apple Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
14:30		Warsh to Reiterate Fed’s Pledge to Get Inflation Down
14:30		Warsh to Reiterate Fed’s Pledge to Get Inflation Down
14:30		Starlink Mobile Service Could Be Coming to the U.S. Market Soon. Are Top Telecom Stocks in Trouble?
14:25		Jamie Dimon Delivers Mixed Message: Economy Is Resilient, But Market Risks Are Mounting
14:25		FNB Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
14:23		As the world rearms, South Korea aims to cash in
14:19		Micron To Rally Around 87%? Here Are 10 Top Analyst Forecasts For Tuesday
14:18		Best Buy vs. GameStop: What Their Revenue Trends Tell Investors About These Specialty Retailers
14:18		Is SentinelOne the Next CrowdStrike?
14:15		Adnovum startet mit Quantum Resilience Services
14:15		Nigeria offers clues to new US Africa strategy
14:15		I’m 45 and want to buy an apartment. How can I turn $1,000 into $250,000?
14:12		ServiceNow Stock Falls in Sympathy With IBM After Disappointing Preliminary Q2 Results
14:07		Hormuz is No Suez or Panama Canal, Says Global Shipping Giant, Slams Trump's 20% Toll as 'Fundamentally Wrong'
14:05		Paramount vs. the States
14:05		Forget Micron And SanDisk: Ray Wang Says China's CXMT Is 'Already A Very Serious Player'—But 4 Years Behind SK Hynix
14:05		Jeff Bezos' Blue Origin Scrapped Its Destroyed Launchpad and Plans to Return to Flight by December 2026 Using a New Hybrid Launch System.
14:03		Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
14:00		Chai Discovery, an A.I. Drug Start-Up, Raises $400 Million
14:00		Could This "Magnificent Seven" Stock End Up Being Nvidia's Biggest Rival?
14:00		Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals
13:59		Prediction: Oracle Stock Could Hit This Price by 2027
13:56		Why De Beers opted to shut Venetia diamond mine
13:54		Microsoft Made a Lot of Headlines Last Week — Here's What Investors Need To Know
13:50		Will Sandisk Stock Soar After August 5?
13:50		Windows 11: Microsoft entrümpelt Suchmenü und reduziert Werbung
13:46		This Arrowhead Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
13:44		Why Is UMC Stock Trading Higher Today?
13:41		Simmons First National Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
13:40		Another warning sign is flashing for tech stocks — and this one comes from outside the U.S.
13:39		CleanSpark Stock Jumps After Inking $6.6 Billion, 20-Year Data Center Lease in Georgia
13:38		Big Banks Smash Earnings Records, but ‘Tectonic’ Risks Loom
13:37		Zahlen, bitte: Die KI, dein digitaler Replikant
13:34		What's Going on With SK hynix Stock Tuesday?
13:30		The Fed and BoE have a trust deficit
13:30		Planet Labs CEO Sells Company Shares Worth $5.2 Million. Here's What That Means for Investors.
13:30		The SEC Is Developing New Rules for Crypto. Here's Why Crypto Investors Should Pay Attention
13:27		Airbnb co-founder is bullish on tokenization of real-world assets — but one thing is key
13:27		How Much Higher Can the S&P 500 Climb From Here? Wall Street Analysts Share a Resounding Answer.
13:23		Circle President Hails Company's 'Historic' Milestone—So Why Is CRCL Going Down?
13:22		A Director Sold Almost 2 Million Shares of This Oilfield Services Company After a Big Run. Should Investors Follow?

Zurück | 1 | 2 | 3 | 4 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: DBV Technologies Desktop Meta a Mogotes Metals Prime Financial Group Ordell Minerals

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	14.07.2026 21:42
Kaufwert:	EUR
	Hinzufügen Speichern

Rapport Therapeutics Aktie

WKN DE: A40EP8 / ISIN: US75383L1026

Rapport Therapeutics Times and Sales (NAS)

Analysen zu Rapport Therapeutics Inc Registered Shs

Weitere Meldungen